AvroBio Inc Leaps Forward with a Beta Value of 1.28
AvroBio Inc (NASDAQ: AVRO) made an impressive start to trading on November 22, 2023, as the stock surged 0.79% to $1.27. Throughout the day, it reached a high of $1.2799 and a low of $1.24 before settling at $1.26 at the close. Taking a long-term perspective, AVRO has seen a 52-week range of $0.57-$1.93.
In terms of sales growth, AvroBio Inc has recorded 0.00% in the past 5 years, while its Annual Earnings per Share (EPS) during that period was -25.34%. However, this year, the company’s EPS has seen a significant increase to 108.26%. With a total of $43.92 million shares outstanding and a float of $38.21 million, AvroBio Inc currently has a market capitalization of $56.60 million. The stock’s 50-day Moving Average is $1.5048, with the 200-day Moving Average sitting at $1.2890.
Insight into the actions of major investors can offer valuable knowledge. AvroBio Inc has an insider ownership of 14.28% and institutional ownership of 46.66%.
In the company’s recently published earnings report for the last quarter on September 29, 2023, AvroBio Inc posted earnings per share (EPS) of -$0.44, falling short of the forecasted -$0.28 by -$0.16 per share. The company’s return on equity for the period was -86.50%. Market experts anticipate earnings of -0.16 per share for the current fiscal year.
AvroBio Inc has seen a remarkable increase of 108.26% in EPS for the current 12-month fiscal period, with a forecasted EPS of -0.56 for the upcoming year.
Examining the current performance indicators for AvroBio Inc (AVRO), the company’s Quick Ratio in the last reported quarter was 14.44. The stock has an average true range (ATR) of 0.07.
AVRO’s Diluted EPS (Earnings per Share) for the trailing twelve months is recorded as -0.10, and analysts predict it will reach -0.35 in the next quarter. Furthermore, they expect the EPS to be -0.56 at the market close one year from today.
Recent statistics for AvroBio Inc (AVRO) show that its 5-day average volume was lower compared to the volume observed in the same period last year. Over the past 9 days, the stock’s Stochastic %D was recorded at 21.27%, while its Average True Range measured 0.0733.
The raw stochastic average for AvroBio Inc over the previous 100 days is 45.71%, indicating a substantial increase compared to 19.28% in the last 2 weeks. In terms of volatility, the company exhibited historic volatility of 48.56% over the past 14 days, which was lower than the 69.02% volatility observed over the past 100 days.
AvroBio Inc’s performance and financial indicators provide valuable insight into the company’s trajectory. With the potential for future growth, investors and experts will be closely monitoring AVRO in the coming months.
